Moffitt logo

HURRICANE IAN UPDATE: Moffitt is open and working to reschedule patient appointments. Get the latest information.

Clinical Trials Search

Clinical Trial 21889

Cancer Type: Gastrointestinal Tumor
Study Type: Supportive Care
NCT#: NCT05438940

Phase: N/A
Principal Investigator: Turner, Kea

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients

Summary

The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation treatment

Objective

Aim 1: Assess the feasibility, acceptability, and usability of remote malnutrition monitoring among GEC patients initiating chemoradiation. Aim 2: Collect pilot data on malnutrition (weight, BMI, muscle mass), GI symptom burden, quality of life and treatment outcomes among GEC patients initiating chemoradiation.

Treatments

Therapies

Medications

Inclusion Criteria

  • >18 years old
  • GEC diagnosis
  • Planned to initiate chemoradiation (either sequentially or concurrently) with a plan for surgery at Moffitt
  • Able to speak and read English
  • Able to provide informed consent

  • Exclusion Criteria

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse
  • Undergoing concurrent treatment for a secondary primary cancer
  • Use of feeding tubes before enrollment (The last exclusion criterion was included because investigators do not anticipate these participants would benefit from a dietary monitoring intervention

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.